Insider Buy/Sell Details for the Healthcare Sector — March 2026
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (1826)
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,091
Price
$538.41
Total Value
$587.40K
Shares Held After
43,082
% of Holdings
2.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,000
Price
$537.32
Total Value
$537.32K
Shares Held After
44,173
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,840
Price
$536.26
Total Value
$986.71K
Shares Held After
45,173
% of Holdings
3.9%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
727
Price
$535.05
Total Value
$388.98K
Shares Held After
47,013
% of Holdings
1.5%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,076
Price
$534.14
Total Value
$574.74K
Shares Held After
47,740
% of Holdings
2.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
667
Price
$533.16
Total Value
$355.62K
Shares Held After
48,816
% of Holdings
1.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
397
Price
$532.24
Total Value
$211.30K
Shares Held After
49,483
% of Holdings
0.8%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
133
Price
$531.21
Total Value
$70.65K
Shares Held After
49,880
% of Holdings
0.3%
TANDEM DIABETES CARE INC (TNDM)
Novara Mark David — EVP & CHIEF COMMERCIAL OFFICER
Shares
187
Price
$23.05
Total Value
$4.31K
Shares Held After
37,656
% of Holdings
0.5%
Esperion Therapeutics, Inc. (ESPR)
Looker Benjamin — Chief Legal Officer
Shares
5,708
Price
$2.70
Total Value
$15.43K
Shares Held After
679,348
% of Holdings
0.8%
Esperion Therapeutics, Inc. (ESPR)
Halladay Benjamin — Chief Financial Officer
Shares
6,424
Price
$2.71
Total Value
$17.38K
Shares Held After
713,602
% of Holdings
0.9%
Esperion Therapeutics, Inc. (ESPR)
Koenig Sheldon L. — Director
Shares
25,578
Price
$2.72
Total Value
$69.55K
Shares Held After
2,172,699
% of Holdings
1.2%
Hims & Hers Health, Inc. (HIMS)
Becklund Irene — PAO
Shares
5,529
Price
$24.69
Total Value
$136.51K
Shares Held After
8,752
% of Holdings
38.7%
Hims & Hers Health, Inc. (HIMS)
Chi Michael — Chief Operating Officer
Shares
97,289
Price
$24.69
Total Value
$2.40M
Shares Held After
407,282
% of Holdings
19.3%
Hims & Hers Health, Inc. (HIMS)
Boughton Soleil — Chief Legal Officer
Shares
4,812
Price
$24.69
Total Value
$118.81K
Shares Held After
308,831
% of Holdings
1.5%
IRADIMED CORP (IRMD)
Susi Roger E. — Director
Shares
2,500
Price
$102.43
Total Value
$256.08K
Shares Held After
2,240,000
% of Holdings
0.1%
HARVARD BIOSCIENCE INC (HBIO)
DENELSKY STEPHEN J — Director
Shares
10,000
Price
$4.87
Total Value
$48.70K
Shares Held After
21,000
% of Holdings
47.6%
Neuronetics, Inc. (STIM)
Chernett Jorey — 10% Owner
Shares
531,000
Price
$1.16
Total Value
$615.96K
Shares Held After
7,516,404
% of Holdings
7.1%
Nutex Health Inc. (NUTX)
Spears Kelvin — Director
Shares
10
Price
$94.46
Total Value
$944.60
Shares Held After
32,137
% of Holdings
0.0%
Airsculpt Technologies, Inc. (AIRS)
Chernett Jorey — 10% Owner
Shares
83,000
Price
$2.56
Total Value
$212.48K
Shares Held After
6,676,059
% of Holdings
1.2%
HARVARD BIOSCIENCE INC (HBIO)
Snider William — Director
Shares
8,475
Price
$4.85
Total Value
$41.10K
Shares Held After
32,000
% of Holdings
26.5%
IRONWOOD PHARMACEUTICALS INC (IRWD)
DENNER ALEXANDER J — Director
Shares
5,800
Price
$3.31
Total Value
$19.20K
Shares Held After
9,188,635
% of Holdings
0.1%
IRONWOOD PHARMACEUTICALS INC (IRWD)
DENNER ALEXANDER J — Director
Shares
6,725,000
Price
$3.05
Total Value
$20.51M
Shares Held After
9,194,435
% of Holdings
42.2%
Mineralys Therapeutics, Inc. (MLYS)
Rodman David Malcom — Chief Medical Officer
Shares
417
Price
$25.65
Total Value
$10.70K
Shares Held After
76,140
% of Holdings
0.5%
UNITED THERAPEUTICS Corp (UTHR)
MALCOLM JAN — Director
Shares
45
Price
$533.51
Total Value
$24.01K
Shares Held After
125
% of Holdings
26.5%
EKSO BIONICS HOLDINGS, INC. (EKSO)
Jones Jason C — Chief Operating Officer
Shares
1,308
Price
$11.85
Total Value
$15.50K
Shares Held After
4,449
% of Holdings
29.4%
EKSO BIONICS HOLDINGS, INC. (EKSO)
Wong Jerome — Chief Financial Officer
Shares
1,308
Price
$11.85
Total Value
$15.50K
Shares Held After
4,184
% of Holdings
31.3%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
272
Price
$99.05
Total Value
$26.94K
Shares Held After
73,631
% of Holdings
0.4%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
299
Price
$98.21
Total Value
$29.36K
Shares Held After
73,903
% of Holdings
0.4%
GLAUKOS Corp (GKOS)
Navratil Tomas — CHIEF DEVELOPMENT OFFICER
Shares
460
Price
$97.33
Total Value
$44.77K
Shares Held After
74,202
% of Holdings
0.6%
Ginkgo Bioworks Holdings, Inc. (DNA)
Coen Steven P. — Chief Financial Officer
Shares
708
Price
$6.74
Total Value
$4.77K
Shares Held After
9,099
% of Holdings
7.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,766
Price
$13.92
Total Value
$108.07K
Shares Held After
232,699
% of Holdings
3.2%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
15,534
Price
$14.00
Total Value
$217.48K
Shares Held After
240,465
% of Holdings
6.1%
Theravance Biopharma, Inc. (TBPH)
Farnum Rhonda — SVP, COMM & MEDICAL AFFAIRS
Shares
7,767
Price
$13.92
Total Value
$108.09K
Shares Held After
255,999
% of Holdings
2.9%
Centessa Pharmaceuticals plc (CNTA)
Anderson Karen M. — Chief People Officer
Shares
64,768
Price
$28.21
Total Value
$1.83M
Shares Held After
62,085
% of Holdings
51.1%
Adaptive Biotechnologies Corp (ADPT)
RUBINSTEIN JULIE — President and COO
Shares
19,060
Price
$13.41
Total Value
$255.59K
Shares Held After
503,596
% of Holdings
3.6%
Roivant Sciences Ltd. (ROIV)
Epperly Melissa B, — Director
Shares
41,861
Price
$28.68
Total Value
$1.20M
Shares Held After
15,804
% of Holdings
72.6%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
3,961
Price
$37.77
Total Value
$149.61K
Shares Held After
112,018
% of Holdings
3.4%
Crinetics Pharmaceuticals, Inc. (CRNX)
Knight Jeff E. — Chief Operating Officer
Shares
5,950
Price
$37.11
Total Value
$220.80K
Shares Held After
115,979
% of Holdings
4.9%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
15,886
Price
$50.49
Total Value
$802.08K
Shares Held After
17,044
% of Holdings
48.2%
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Bhatt Padmanabh P. — Sr. VP of IP, CSO
Shares
34,114
Price
$50.18
Total Value
$1.71M
Shares Held After
32,930
% of Holdings
50.9%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
9,440
Price
$72.77
Total Value
$686.90K
Shares Held After
92,832
% of Holdings
9.2%
IONIS PHARMACEUTICALS INC (IONS)
HOUGEN ELIZABETH L — EVP, Finance & CFO
Shares
205,608
Price
$72.38
Total Value
$14.88M
Shares Held After
102,272
% of Holdings
66.8%
BiomX Inc. (PHGE)
Yeganeh Reuven — Director
Shares
450,000
Price
$5.00
Total Value
$2.25M
Shares Held After
0
% of Holdings
100.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
8,785
Price
$37.77
Total Value
$331.81K
Shares Held After
404,778
% of Holdings
2.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Struthers Richard Scott — Director
Shares
13,196
Price
$37.11
Total Value
$489.70K
Shares Held After
413,563
% of Holdings
3.1%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
4,241
Price
$37.77
Total Value
$160.18K
Shares Held After
137,101
% of Holdings
3.0%
Crinetics Pharmaceuticals, Inc. (CRNX)
Betz Stephen F. — Chief Scientific Officer
Shares
6,371
Price
$37.11
Total Value
$236.43K
Shares Held After
141,342
% of Holdings
4.3%
WATERS CORP /DE/ (WAT)
Jiang Wei — Director
Shares
500
Price
$289.46
Total Value
$144.73K
Shares Held After
3,441
% of Holdings
14.5%
ARDELYX, INC. (ARDX)
RAAB MICHAEL — Director
Shares
41,666
Price
$5.84
Total Value
$243.33K
Shares Held After
1,816,448
% of Holdings
2.2%
Showing 201–250 of 1826 transactions (page 5 of 37)